Pr3vent
Pr3vent Inc., a US-based AI healthcare company, develops machine learning screens for newborn ophthalmic conditions.
Founded
2017Pr3vent Inc., a US-based AI healthcare company, develops machine learning screens for newborn ophthalmic conditions.
Pr3vent Inc., founded with the mission to protect and enhance infant vision, is a US-based AI healthcare company specializing in machine learning screens for newborn ophthalmic conditions. The company's core vision is to ensure better vision and a brighter future for infants through advanced newborn vision screening. Pr3vent offers professional imaging and expert evaluation services that screen more of the eye, enabling early detection and protection of infant vision. Their market focus is on healthcare providers and parents in the United States who seek proactive measures for their newborns' eye health.
Notable affiliated people and investors include leading experts in ophthalmology and artificial intelligence, though specific names are not provided. Key achievements of Pr3vent include the development and deployment of advanced AI-driven screening tools that have significantly improved early detection rates of ophthalmic conditions in newborns. The overall impact of Pr3vent has been substantial, providing peace of mind to parents and facilitating early interventions that can prevent long-term vision problems in children.
Companies similar to Pr3vent include Preventa Medical, Vifant, Youth Healthtech and iScreen Vision.
Pr3vent was founded in 2017.
Pr3vent's headquarters is located in Palo Alto, CA, US.
Pr3vent's most recent funding round was for $1.5M (USD) in February 2019.
As of Feb 12, 2019, Pr3vent has disclosed funding of $1.5M (USD). Undisclosed round amounts are excluded.
Pr3vent has 8 employees as of Feb 4, 2024.
